论文信息 - Integrated data review of the first-in-human dose (FHD) study evaluating safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor, LY2157299 monohydrate (LY). - 字舞流文

Integrated data review of the first-in-human dose (FHD) study evaluating safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor, LY2157299 monohydrate (LY).

J. Baselga | J. Seoane | M. Carducci | L. Paz-Ares | I. Braña | M. Holdhoff | J. Blakeley | A. Cleverly | E. Calvo | J. Sepúlveda | D. Desaiah | I. Gueorguieva | M. Lahn | A. Azaro | E. Sicart | J. Rodón | S. Pillay